PL139828B1 - Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines - Google Patents

Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines Download PDF

Info

Publication number
PL139828B1
PL139828B1 PL1981239280A PL23928081A PL139828B1 PL 139828 B1 PL139828 B1 PL 139828B1 PL 1981239280 A PL1981239280 A PL 1981239280A PL 23928081 A PL23928081 A PL 23928081A PL 139828 B1 PL139828 B1 PL 139828B1
Authority
PL
Poland
Prior art keywords
group
diamino
compound
formula
hydrogen
Prior art date
Application number
PL1981239280A
Other languages
English (en)
Polish (pl)
Other versions
PL239280A1 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PL239280A1 publication Critical patent/PL239280A1/xx
Publication of PL139828B1 publication Critical patent/PL139828B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL1981239280A 1980-11-11 1981-11-10 Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines PL139828B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (2)

Publication Number Publication Date
PL239280A1 PL239280A1 (en) 1983-08-01
PL139828B1 true PL139828B1 (en) 1987-02-28

Family

ID=10517217

Family Applications (4)

Application Number Title Priority Date Filing Date
PL1981239280A PL139828B1 (en) 1980-11-11 1981-11-10 Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines
PL1981239279A PL139427B1 (en) 1980-11-11 1981-11-10 Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines
PL1981233754A PL139523B1 (en) 1980-11-11 1981-11-10 Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines
PL1981239278A PL139827B1 (en) 1980-11-11 1981-11-10 Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines

Family Applications After (3)

Application Number Title Priority Date Filing Date
PL1981239279A PL139427B1 (en) 1980-11-11 1981-11-10 Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines
PL1981233754A PL139523B1 (en) 1980-11-11 1981-11-10 Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines
PL1981239278A PL139827B1 (en) 1980-11-11 1981-11-10 Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines

Country Status (35)

Country Link
US (4) US4438267A (enExample)
EP (1) EP0051879B1 (enExample)
JP (1) JPS57114581A (enExample)
KR (1) KR880001736B1 (enExample)
AR (1) AR245447A1 (enExample)
AU (1) AU549449B2 (enExample)
CA (1) CA1186310A (enExample)
CS (1) CS273153B2 (enExample)
CY (1) CY1419A (enExample)
DD (1) DD201896A5 (enExample)
DE (1) DE3173752D1 (enExample)
DK (1) DK172884B1 (enExample)
EG (1) EG16107A (enExample)
ES (5) ES8307759A1 (enExample)
FI (1) FI76333C (enExample)
GB (1) GB2087881B (enExample)
GR (1) GR81317B (enExample)
HK (1) HK23388A (enExample)
HU (1) HU188762B (enExample)
IE (1) IE52128B1 (enExample)
IL (1) IL64256A (enExample)
IT (1) IT1210589B (enExample)
MC (1) MC1418A1 (enExample)
MY (1) MY8600678A (enExample)
NO (2) NO160137C (enExample)
NZ (1) NZ198932A (enExample)
PH (2) PH22654A (enExample)
PL (4) PL139828B1 (enExample)
PT (1) PT73960B (enExample)
RU (1) RU1819264C (enExample)
SG (1) SG62686G (enExample)
SU (4) SU1424732A3 (enExample)
YU (5) YU42444B (enExample)
ZA (1) ZA817780B (enExample)
ZM (1) ZM9481A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
DE69618986T2 (de) * 1995-12-04 2002-06-20 Arpida Ag, Muenchenstein Diaminopyrimidine, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung als antibakterielle mittel
RU2141322C1 (ru) * 1997-08-12 1999-11-20 Голощапов Николай Михайлович Иммуномодулятор с антимикобактериальной активностью "изофон", способ его получения и применения
GB0016877D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Chemical compounds
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
DK1401413T3 (da) * 2001-06-29 2007-03-26 Ab Science Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme
EP1401415B1 (en) * 2001-06-29 2006-06-21 AB Science Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases
CA2452368A1 (en) * 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
WO2003004007A2 (en) 2001-06-29 2003-01-16 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd)
ATE401078T1 (de) * 2001-09-20 2008-08-15 Ab Science Die verwendung von c-kithemmern zur förderung des haarwuchses
US20040242601A1 (en) * 2001-09-20 2004-12-02 Alain Moussy Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
DE60225590T2 (de) * 2001-09-20 2008-09-25 Ab Science C-kithemmer zur behandlung von bakteriellen infektionen
BRPI0412425A (pt) * 2003-07-11 2006-09-05 Arpida Ag compostos, intermediários, composições farmacêuticas, uso de um ou mais compostos, e, processo para a manufatura de composições farmacêuticas
MX2007009282A (es) * 2005-02-18 2008-02-19 Arpida Ag Nuevos procesos para la preparacion de un 2h-cromeno.
JP4850912B2 (ja) * 2005-09-01 2012-01-11 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３およびｐ３ｘ２／３モジュレーターとしてのジアミノピリミジン
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
US20120122819A1 (en) * 2009-06-12 2012-05-17 Socpra - Sciences Et Genie S.E.C. Guanine riboswitch binding compounds and their use as antibiotics
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2，4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2，4-(1h，3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
KR20220016909A (ko) * 2019-06-06 2022-02-10 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 P2x3 및/또는 p2x2/3 수용체 길항제, 이를 함유하는 약학적 조성물 및 이의 용도
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
WO2022217295A1 (en) * 2021-04-09 2022-10-13 The Trustees Of The University Of Pennsylvania Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
PL139523B1 (en) 1987-01-31
PT73960A (en) 1981-12-01
PL239280A1 (en) 1983-08-01
ES521201A0 (es) 1984-06-01
EP0051879B1 (en) 1986-02-05
FI76333C (fi) 1988-10-10
JPS57114581A (en) 1982-07-16
NO160137B (no) 1988-12-05
IL64256A (en) 1988-01-31
NO1994029I1 (no) 1994-12-29
HU188762B (en) 1986-05-28
KR830007628A (ko) 1983-11-04
PH25053A (en) 1991-01-28
HK23388A (en) 1988-04-08
SU1535379A3 (ru) 1990-01-07
MC1418A1 (fr) 1982-10-18
PL139427B1 (en) 1987-01-31
EG16107A (en) 1987-10-30
PL239278A1 (en) 1983-08-01
YU198183A (en) 1984-04-30
PL233754A1 (en) 1983-08-01
RU1819264C (ru) 1993-05-30
ES8405377A1 (es) 1984-06-01
DK172884B1 (da) 1999-09-06
NO160137C (no) 1989-03-15
FI76333B (fi) 1988-06-30
IE812631L (en) 1982-05-11
IE52128B1 (en) 1987-06-24
IL64256A0 (en) 1982-02-28
ES521204A0 (es) 1984-06-01
CS825781A2 (en) 1990-07-12
US4761475A (en) 1988-08-02
PL239279A1 (en) 1983-08-01
YU43551B (en) 1989-08-31
YU46697B (sh) 1994-04-05
US4603136A (en) 1986-07-29
EP0051879A2 (en) 1982-05-19
ES506969A0 (es) 1983-07-01
PL139827B1 (en) 1987-02-28
ZM9481A1 (en) 1983-11-21
AR245447A1 (es) 1994-01-31
PT73960B (en) 1983-11-23
IT1210589B (it) 1989-09-14
EP0051879A3 (en) 1982-08-04
DE3173752D1 (en) 1986-03-20
SU1424732A3 (ru) 1988-09-15
AU549449B2 (en) 1986-01-30
DD201896A5 (de) 1983-08-17
NO813804L (no) 1982-05-12
FI813546L (fi) 1982-05-12
MY8600678A (en) 1986-12-31
KR880001736B1 (ko) 1988-09-10
YU198383A (en) 1984-04-30
GB2087881B (en) 1985-05-15
CS273153B2 (en) 1991-03-12
YU266381A (en) 1984-04-30
GB2087881A (en) 1982-06-03
ZA817780B (en) 1983-06-29
SU1318148A3 (ru) 1987-06-15
ES8405378A1 (es) 1984-06-01
ES8307759A1 (es) 1983-07-01
CY1419A (en) 1988-04-22
GR81317B (enExample) 1984-12-11
ES521203A0 (es) 1984-06-01
JPH0474351B2 (enExample) 1992-11-26
NZ198932A (en) 1985-05-31
AU7733481A (en) 1982-05-20
CA1186310A (en) 1985-04-30
ES8405379A1 (es) 1984-06-01
ES8405380A1 (es) 1984-06-01
YU198283A (en) 1984-04-30
YU42444B (en) 1988-08-31
US4438267A (en) 1984-03-20
DK496681A (da) 1982-05-12
YU144288A (en) 1990-04-30
PH22654A (en) 1988-10-28
SG62686G (en) 1987-03-27
ES521202A0 (es) 1984-06-01
US4587342A (en) 1986-05-06
IT8149676A0 (it) 1981-11-10
SU1306473A3 (ru) 1987-04-23

Similar Documents

Publication Publication Date Title
PL139828B1 (en) Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines
DE69530989T2 (de) Neue pyrimidinderivate und verfahren zu ihrer herstellung
DE60025848T2 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
PL151571B1 (en) Hydroxy and alkoxy pyrimidines.
US4515948A (en) 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
AU2022200967A1 (en) Compositions and methods for treating infections
US4236004A (en) 2-Alkylsulphonyl-7,8-dihydro-5-hydroxy-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
IE843237L (en) 5 - pyrimidine carboxamides and thiocarbox amides
DE3615180C2 (de) Disubstituierte 1,4-Piperazinylderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
US4590271A (en) 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
US4992444A (en) Antifolate agents
CH591457A5 (enExample)
NO782340L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
EP0054756A2 (en) Antibacterial benzylpyrimidines
US4565864A (en) Substituted imidazo[1,2-c]pyrimidines
PL101046B1 (pl) Sposob wytwarzania nowych benzylopirymidyn
US3772272A (en) 4,6-diaryl-pyrimidin-2(1h)-ones
US3818001A (en) 1,2,3-benzotriazin-4(3h)-ones
US3963719A (en) 6-Spirocycloalkylamino 5-nitropyrimidines
US4042589A (en) Pteridine compounds
US4379786A (en) N-Aryl-N-(4,5,6,7-tetrahydro-1H-1,3, diazepin-2-yl)ureas as antihypertensives
DE19933164A1 (de) Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten
KR810001653B1 (ko) 7-(치환된)-7H-피롤로〔3, 2-f〕퀴나졸린-1, 3-디아민 유도체의 제조방법
WO1983002113A1 (fr) Derives de propenylamine et medicaments les contenant